Transatlantic exchanges: a third edition dedicated to liquid biopsy in cancer treatment

The third edition of the Transatlantic Exchanges will be held in Boston on April 12th, 2024. Broadcast online live, this day of exchanges is an opportunity to follow high-level debates on the perspectives opened by liquid biopsy in precision oncology. The detailed program and enrollment are available: https://na.eventscloud.com/website/68476/.

The Third Transatlantic Exchange in Oncology: Liquid Biopsy as an Emerging Approach in Precision Cancer Medicine

Organized annually for the past three years between The United States and France, the Transatlantic Exchanges will be held for their third edition in Boston, on April 12th, 2024, and will be broadcast simultaneously online on the platform Medscape.

This one-day meeting is organized by two global leaders in oncology, respectively ranked 4th and 8th globally: Gustave Roussy and the Dana-Farber Cancer Institute. This year, the debates will focus on liquid biopsy and the role it can play in the future of precision oncology for the benefit of patients.

High-ranking participants

The 2024 edition is co-chaired by Toni Choueiri, MD, Medical Director of International Strategic Initiatives and director of the Lank Center for Genitourinary Oncology at Dana-Farber and Karim Fizazi, MD, PhD, head of the International Academic Network at Gustave Roussy. Moderators include : Fabrice André, MD, PhD, head of research at Gustave Roussy, Gérard Friedlander, MD, PhD, from Paris-Cité University, and Matthew Freedman, MD, of Dana-Farber Cancer Institute and Harvard Medical School. The keynote speaker is Victor Velculescu, MD, PhD, professor of Oncology and Pathology and Co-Director of Cancer Biology at the Sidney Kimmel Cancer Center at Johns Hopkins University, who will discuss the future of liquid biopsy in cancer medicine.

Many doctors and researchers from Gustave Roussy are expected : Benjamin Besse, MD, Ph.D., head of clinical research, Suzette Delaloge, MD, MSc, head of the Interception program, Françoise Farace, Ph.D., research director, Antoine Italiano, MD, Ph.D., in charge of the precision medicine program, Alexandra Leary, MD, Ph.D., deputy chief of the oncological medicine department, Yohann Loriot, MD, Ph.D., deputy chief at the early trials department (DITEP) and Ines Vaz-Luis, MD, MSc, deputy chief of the interdisciplinary patient's path department.  

Enrollments are open

This meeting, which will be held at Revere Hotel Boston Common, will be broadcast live on Medscape. Healthcare professionals who are looking to follow the discussions can already enroll themselves.

For the live retransmission, enroll here.

These Transatlantic Exchanges, which have in the past focused on immuno-oncology, AI and data science, result from an agreement passed between Gustave Roussy and the Dana-Farber Cancer Institute, supported by l’Institut Servier. The collaboration includes annual conferences alternating between Boston, USA, and Paris, France, and also fosters scientific collaboration between these two major institutions by enabling a biennial fellowship program for four young researchers, and post-doctoral students from Gustave Roussy, who are hosted with the Dana-Farber teams.